Posted under Blog on June 7th, 2013 by Editorial Team / No Comments
Looking at a piece of art work can sharpen concentration, revive long-forgotten memories, inspire creativity and invoke emotional responses. This response can also be noted in people with Alzheimer’s disease, allowing them to connect with loved ones in a non-verbal way and offering them an opportunity to express their feelings.
Groups such as The Hilgos Foundation, a non-profit organization that supports the on-going process of artistic creation for people with memory impairment, have done an excellent job in raising awareness of art therapy and showcasing its many benefits. Many care homes across America and Western Europe have begun integrating art therapy into the daily routines of Alzheimer’s patients. The introduction of the arts and other creative activities is now being recognised as a way of maintaining a higher quality of life for residents.
Through the creative arts, carers can engage patients and bypass some of the limitations of the disease. Whether it is painting, sketching, or clay modelling, art stimulates not only the eyes, but also the whole body. This interaction can encourage a person to reconnect with old memories and functions, allowing them to express their independence and identity.
Dr Sam Gandy, Associate Director at Mount Sinai Alzheimer’s Disease Research Center in NYC, encourages this new form of therapy: “There are parts of the brain that do not deteriorate until the condition is in its late stage, this allows activities such as art therapy to still stimulate patients’ senses who are suffering from the disease.”
The School of the Art Institute of Chicago has recently been pioneering a new offering for Alzheimer’s patients, allowing them to take private tours of the gallery. Patients may still be able to process the color, form and shape of a piece of art and this translates into better communication amongst the visitors. Carers have reported that patients can express themselves with greater freedom and fluidity after touring the exhibitions.
While scientists continue to carry out vital research into the treatment of Alzheimer’s, the arts can go some way to relieving some of the disease’s most difficult symptoms, help maintain patients’ independence and indignity and provide them with a meaningful creative outlet.
Tags: Art therapy, Early Alzheimer's, treatment
Posted under Blog on July 13th, 2012 by Editorial Team / No Comments
Two pieces of research published this week reveal a timeline for the development of Alzheimer’s and a protective gene that helps to prevent the disease in a small percentage of the population. The two papers are published in the scientific journals The New England Journal of Medicine and Nature.
Alzheimer’s timeline might help early treatment and diagnosis
Scientists at the Washington University School of Medicine studied individuals with a genetic risk for early onset Alzheimer’s. They revealed that changes in the brain occur at least two decades before the onset of clinical symptoms, suggesting that current diagnoses are usually made at an advanced stage of the disease’s biological development.
These results may have dramatic implications for the diagnosis and treatment of those at risk of developing Alzheimer’s at an early age.
“The ability to detect the very earliest stages of Alzheimer's would not only allow people to plan and access care and existing treatments far sooner, but would also enable new drugs to be trialled in the right people, at the right time," commented Dr Eric Karran, director of Research at Alzheimer's Research UK.
Links:
http://www.bbc.co.uk/news/health-18796309
http://www.nejm.org/doi/full/10.1056/NEJMoa1202753?query=featured_home
Rare protective gene prevents Alzheimer’s
A few lucky people appear to carry a genetic mutation which prevents them from developing Alzheimer’s.
The mutation — the first ever found to protect against the disease — lies in a gene that produces amyloid precursor protein (APP), which has long been suspected to be at the heart of Alzheimer’s although its function is still largely unknown. This research does seem to point a finger at amyloid-β, the target for several therapies being investigated to see if they can slow the development and progression of Alzheimer’s. However, scientists say this doesn’t mean it’s the only factor.
Links:
http://www.nature.com/news/gene-mutation-defends-against-alzheimer-s-disease-1.10984
http://www.reuters.com/article/2012/07/11/us-alzheimers-idUSBRE86A0WV20120711
Tags: AAIC, Alzheimer's Association International Conference, diagnosis, Early Alzheimer's, research, The New England Journal, treatment
Posted under Blog on March 14th, 2012 by Editorial Team / No Comments
A new report by the UK patient group The Alzheimer’s Society has revealed that six in every ten dementia sufferers remain undiagnosed.
This revelation sadly also diminishes the excitement of last week’s news; that Alzheimer’s sufferers can benefit from drugs longer than first thought. It was previously believed that anti-dementia drugs were effective only in the early stages, but work at King’s College London has shown medication to remain effective even in the severe stages.
However, the UK seems to be in the midst of an epidemic. Not of Alzheimer’s but, as The Daily Telegraph reports, a case of ‘therapeutic nihilism’. This is the belief that it is pointless trying to help an individual with Alzheimer’s and consequently individuals are not encouraged to visit their GP.
Although currently there is no cure, treatment can make a real difference to someone’s life but only if doctors get to see the patient.
For more information on the early signs and symptoms of Alzheimer’s please explore this site.